NASDAQ:ADN - Nasdaq - US00788A2042 - Common Stock - Currency: USD
1.9
-0.07 (-3.55%)
The current stock price of ADN is 1.9 USD. In the past month the price decreased by -60.5%. In the past year, price decreased by -58.22%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ETN | EATON CORP PLC | 26.74 | 113.15B | ||
EMR | EMERSON ELECTRIC CO | 18.63 | 59.37B | ||
AME | AMETEK INC | 24.41 | 38.46B | ||
VRT | VERTIV HOLDINGS CO-A | 28.42 | 33.11B | ||
ROK | ROCKWELL AUTOMATION INC | 26.12 | 28.08B | ||
HUBB | HUBBELL INC | 21.73 | 19.28B | ||
NVT | NVENT ELECTRIC PLC | 19.5 | 9.02B | ||
AYI | ACUITY INC | 15.04 | 7.50B | ||
RRX | REGAL REXNORD CORP | 11.73 | 7.10B | ||
GNRC | GENERAC HOLDINGS INC | 15.51 | 6.73B | ||
NXT | NEXTRACKER INC-CL A | 11.22 | 6.36B | ||
ENS | ENERSYS | 9.29 | 3.41B |
Advent Technologies Holdings, Inc. operates as an advanced materials and technology development company. The company is headquartered in Boston, Massachusetts and currently employs 100 full-time employees. The company went IPO on 2018-11-16. The firm develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. Its core product offerings are full fuel cell systems and the Membrane Electrode Assembly (MEA) at the center of the fuel cell. The firm develops and manufactures high-temperature proton exchange membranes (HT-PEM or HT-PEMs) and fuel cell systems. Its systems are aimed to provide stationary power for the off-grid, backup, critical infrastructure, and portable markets. The firm also develops and manufactures MEAs, and designs fuel cell stacks and complete fuel cell systems for a range of customers in the stationary power, portable power, automotive, aviation, energy storage and sensor markets.
ADVENT TECHNOLOGIES HOLDINGS
500 Rutherford Avenue, Suite 102
Boston MASSACHUSETTS 15650 US
CEO: Vassilios Gregoriou
Employees: 100
Company Website: https://www.advent.energy/
Investor Relations: https://ir.advent.energy/
Phone: 18572647035
The current stock price of ADN is 1.9 USD. The price decreased by -3.55% in the last trading session.
The exchange symbol of ADVENT TECHNOLOGIES HOLDINGS is ADN and it is listed on the Nasdaq exchange.
ADN stock is listed on the Nasdaq exchange.
ADVENT TECHNOLOGIES HOLDINGS (ADN) has a market capitalization of 5.02M USD. This makes ADN a Nano Cap stock.
ADVENT TECHNOLOGIES HOLDINGS (ADN) currently has 100 employees.
ADVENT TECHNOLOGIES HOLDINGS (ADN) has a resistance level at 3.33. Check the full technical report for a detailed analysis of ADN support and resistance levels.
The Revenue of ADVENT TECHNOLOGIES HOLDINGS (ADN) is expected to grow by 2705.94% in the next year. Check the estimates tab for more information on the ADN EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ADN does not pay a dividend.
ADVENT TECHNOLOGIES HOLDINGS (ADN) will report earnings on 2025-08-11, after the market close.
ADVENT TECHNOLOGIES HOLDINGS (ADN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-26.95).
The outstanding short interest for ADVENT TECHNOLOGIES HOLDINGS (ADN) is 1.81% of its float. Check the ownership tab for more information on the ADN short interest.
ChartMill assigns a fundamental rating of 2 / 10 to ADN. Both the profitability and financial health of ADN have multiple concerns.
Over the last trailing twelve months ADN reported a non-GAAP Earnings per Share(EPS) of -26.95. The EPS increased by 48.87% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -885.29% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 45% to ADN. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 98.1% and a revenue growth 2705.94% for ADN